Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus
Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, immunogenicity, and antiviral effects of
multiple intravenous doses of ANZ-521 in patients with chronic Hepatitis C virus.